Venu Holding Corp (VENU) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
VENU currently has 60M outstanding shares. with significant dilution risk as 102M authorized shares could dilute existing holders by 169.6%. The company has significantly diluted shareholders by 54.48% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 31, 2026 |
10-K filing | 60.0M shares outstanding |
60M | 100M |
| Mar 11, 2026 |
8-K filing: Venu Holding Corporation completed a public offering of common stock, pre-funded warrants, and common warrants, generating net proceeds of approximately $80.1 million. |
43M | 100M |
| Jan 09, 2026 |
8-K filing: Venu Holding Corporation entered into an amendment to a letter of intent with Aramark, where Aramark committed to an additional $10,005,000 equity investment in the Company by purchasing 667 additional shares of Series B Preferred Stock. ($10.01M proceeds) |
43M | 100M |
| Dec 01, 2025 |
S-3 filing: Venu Holding Corporation may offer and sell, from time to time, either individually or in units, common stock, preferred stock, and debt securities up to a total of $1,000,000,000. |
43M | 100M |
| Nov 14, 2025 |
10-Q filing | 42.8M shares outstanding |
43M | 3M |
| Sep 09, 2025 |
8-K filing: Tixr, Inc. purchased 62,500 shares of Venu Holding Corporation's common stock on September 3, 2025, in exchange for an equity investment as part of a strategic agreement between the two companies. |
38M | 3M |
| Aug 22, 2025 |
S-1 filing: This is a firm commitment public offering of shares of common stock of Venu Holding Corporation at an assumed public offering price of $17.40 per share. |
38M | 3M |
| Jun 26, 2025 |
8-K filing: Venu Holding Corporation filed a Certificate of Designation for Series A Preferred Stock and issued 1,542,367 shares of Common Stock upon conversion of convertible promissory notes. |
38M | 1M |
| Jun 17, 2025 |
8-K filing: Venu Holding Corporation issued 675 shares of Series B Preferred Stock to Aramark at a per share purchase price of $15,000, resulting in a total investment of $10.125 million. ($10.13M proceeds) |
38M | 1M |
| Jun 10, 2025 |
8-K filing: Venu Holding Corporation entered into a letter of intent with Aramark for exclusive services at its amphitheaters, contemplating a $10.125 million equity investment in preferred stock convertible to common stock, and KWO converted debt into 1,007,292 shares of common stock. |
38M | 1M |
| May 15, 2025 |
10-Q filing | 37.5M shares outstanding |
38M | 1M |
| Mar 31, 2025 |
10-K filing | 37.5M shares outstanding |
37M | 1M |
| Jan 17, 2025 |
8-K filing: Venu Holding Corporation entered into a Series A Preferred Stock Purchase Agreement with FL101, Inc. for 1,487,099 shares of FL101's Series A Preferred Stock in exchange for $1,999,999.45, and closed on the purchase of the McKinney Tract for $35,000,000. ($2.0M proceeds) |
37M | 1M |
| Dec 23, 2024 |
10-Q filing | 37.5M shares outstanding |
37M | 1M |
| Nov 12, 2024 |
S-1/A filing: An S-1/A filing on 2024-11-12 details an offering of common stock with estimated net proceeds of approximately $9.0 million, or approximately $10.4 million if the underwriter exercises its over-allotment option in full, at an assumed initial public offering price of $10.00 per share. The net proceeds are intended for corporate level expenditures, sales, marketing, investor relations and business development expenses, costs and expenses related to market expansion and related due diligence activities, and working capital and other general corporate purposes. |
N/A | 1M |
| Nov 08, 2024 |
S-1/A filing: This S-1/A filing details an over-allotment option granted to underwriters, allowing them to purchase up to 15% additional shares of common stock from the company within 45 days after the effective date. |
N/A | 1M |
| Oct 21, 2024 |
S-1/A filing: The company files an S-1/A form and estimates net proceeds of approximately $9.0 million from the sale of common stock, or approximately $10.4 million if the underwriter's over-allotment option is exercised in full, at an assumed initial public offering price of $10.00 per share. The net proceeds will be used for corporate level expenditures, including sales, marketing, investor relations, business development expenses, market expansion costs, and working capital. |
N/A | 1M |
| Sep 19, 2024 |
S-1/A filing: The company is offering common stock with an estimated net proceeds of $9.0 million at an assumed IPO price of $10.00 per share. The proceeds will be used for sales, marketing, investor relations, business development, land acquisition, permitting, venue design, and working capital. |
N/A | 900K |
| Aug 06, 2024 |
S-1 filing: This is a firm commitment initial public offering of shares of Class D Common Stock of Notes Live, Inc. at an anticipated price of $10.00 per share. |
N/A | 0 |